儿童青少年精神分裂症的药物治疗.ppt

儿童青少年精神分裂症的药物治疗 参 考 文 献 中华医学会精神病学分会. 精神分裂症防治指南（第二版）.2015.(140). 精神病学（第五版） American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry.  2013 Sep;52(9):976-90. Howes OD, et al. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. Am J Psychiatry. 2016 Dec 6:appiajp201616050503. Hiemke C, Baumann P, Bergemann N,等. AGNP精神科治疗药物监测共识指南:2011[J]. 实用药物与临床, 2016, 19(10). Correll C U, Manu P, Olshanskiy V, et al. Cardiometabolic Risk of Second-Generation Antipsychotics During First-Time Use in Children and Adolescents[J]. Jama the Journal of the American Medical Association, 2009, 302(16):1765-1773. 定 义 儿童青少年精神分裂：起病年龄18岁的一种病因未明，临床上以基本个性改变、特征性思维障碍、感知觉异常、情感与环境不协调、孤独性表现为主要特征的精神障碍。 儿童青少年精神分裂症分为： 起病年龄13～18岁的早发性精神分裂症 起病年龄13岁的儿童期发病的精神分裂。 儿童青少年精神分裂症的诊断，与成人相同，不考虑发病年龄。 American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry.  2013 Sep;52(9):976-90. 儿童青少年期抗精神病药物使用现状 中华医学会精神病学分会. 精神分裂症防治指南（第二版）.2015.(140). American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry.  2013 Sep;52(9):976-90. 选 药 原 则 中华医学会精神病学分会. 精神分裂症防治指南（第二版）.2015.(140). American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry.  2013 Sep;52(9):976-90. 2016年12月6日AJP发表的难治性精神分裂症标准 Howes OD, et al. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. Am J Psychiatry. 2016 Dec 6:appiajp201616050503. 相 互 作 用 抗精神病药